Skip to main content
. 2016 Apr 26;7(24):37305–37318. doi: 10.18632/oncotarget.9032

Table 5. Kaplan-Meier univariate analysis of patients with PFH.

Variable n 5-Year survival rate (%) P value
Sex 0.540
 Male 259 57.1
 Female 123 65.8
Age (yr) 0.380
 <60 242 60.7
 ≥60 140 58.9
Tumor size (cm) <0.001
 <5 267 67.9
 ≥5 115 41.3
Histological type 0.160
 Differentiated 76 65.9
 Undifferentiated 306 57.9
Tumor location <0.001
 Upper third 97 50.3
 Middle third 67 61.9
 Lower third 192 68.5
 Two-third or more 26 23.1
Borrmann type <0.001
 0 88 91.4
 I 3 0.0
 II 93 63.9
 III 180 44.7
 IV 18 33.3
Vascular tumor emboli <0.001
 Yes 137 37.6
 No 245 71.5
Nervous invasion <0.001
 Yes 151 41.9
 No 231 71.2
Pathological stage <0.001
IA 73 93.8
IB 47 88.8
IIA 37 73.3
IIB 51 60.8
IIIA 47 58.7
IIIB 48 41.7
IIIC 79 13.8
Smoking 0.833
 Yes 70 57.3
 No 312 60.1
Drinking 0.819
 Yes 41 58.5
 No 341 59.9
P21 expression 0.041
 Positive 219 54.9
 Negative 163 66.8
P53 expression 0.535
 Positive 279 61.1
 Negative 103 55.8
c-myc expression 0.017
 Positive 229 54.8
 Negative 153 66.8
EGFR expression 0.196
 Positive 132 53.0
 Negative 250 63.3
Neu/Her-2 0.545
 Positive 4 50.0
 Negative 378 60.1